The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients.

El-Naggar, Abdel Rahman

The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients. [electronic resource] - Journal of cardiovascular pharmacology and therapeutics 05 2019 - 254-261 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

1940-4034

10.1177/1074248418817345 doi


Adult
Antihypertensive Agents--adverse effects
Biomarkers--blood
Blood Pressure--drug effects
Captopril--adverse effects
Diabetes Mellitus, Type 2--blood
Dipeptidyl-Peptidase IV Inhibitors--adverse effects
Egypt
Female
Glycated Hemoglobin--metabolism
Humans
Hypertension--blood
Insulin Resistance
Lipids--blood
Male
Metformin--adverse effects
Middle Aged
Prospective Studies
Time Factors
Treatment Outcome
Vascular Endothelial Growth Factor A--blood
Vildagliptin--adverse effects